[ CAS No. 3270-97-1 ] {[proInfo.proName]}

Name: 3270-97-1|2,4-Diamino-6-methoxypyrimidine|97%
Brand: Ambeed
SKU: A182627
Price: 8.0 USD
Availability: InStock
Rating: 97 (40 reviews)

,{[proInfo.pro_purity]}

Cat. No.: {[proInfo.prAm]}

DV 2D 3D

3d Animation Molecule Structure of 3270-97-1

Structure of 3270-97-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

For Research Only 120K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 3270-97-1 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 3270-97-1 ]

SDS Specification

Alternatived Products of [ 3270-97-1 ]

Product Details of [ 3270-97-1 ]

CAS No. :	3270-97-1	MDL No. :	MFCD02091088
Formula :	C₅H₈N₄O	Boiling Point :	-
Linear Structure Formula :	-	InChI Key :	OSBMJXWHJWWZJP-UHFFFAOYSA-N
M.W :	140.14	Pubchem ID :	816925
Synonyms :

Calculated chemistry of [ 3270-97-1 ] Expand+

Physicochemical Properties

Num. heavy atoms :	10
Num. arom. heavy atoms :	6
Fraction Csp3 :	0.2
Num. rotatable bonds :	1
Num. H-bond acceptors :	3.0
Num. H-bond donors :	2.0
Molar Refractivity :	37.33
TPSA :	87.05 Å²

Pharmacokinetics

GI absorption :	High
BBB permeant :	No
P-gp substrate :	No
CYP1A2 inhibitor :	No
CYP2C19 inhibitor :	No
CYP2C9 inhibitor :	No
CYP2D6 inhibitor :	No
CYP3A4 inhibitor :	No
Log Kp (skin permeation) :	-7.29 cm/s

Lipophilicity

Log Po/w (iLOGP) :	1.12
Log Po/w (XLOGP3) :	-0.19
Log Po/w (WLOGP) :	-0.33
Log Po/w (MLOGP) :	-0.65
Log Po/w (SILICOS-IT) :	-0.5
Consensus Log Po/w :	-0.11

Druglikeness

Lipinski :	0.0
Ghose :	None
Veber :	0.0
Egan :	0.0
Muegge :	1.0
Bioavailability Score :	0.55

Water Solubility

Log S (ESOL) :	-0.97
Solubility :	15.1 mg/ml ; 0.108 mol/l
Class :	Very soluble
Log S (Ali) :	-1.18
Solubility :	9.21 mg/ml ; 0.0658 mol/l
Class :	Very soluble
Log S (SILICOS-IT) :	-1.03
Solubility :	12.9 mg/ml ; 0.0923 mol/l
Class :	Soluble

Medicinal Chemistry

PAINS :	0.0 alert
Brenk :	0.0 alert
Leadlikeness :	1.0
Synthetic accessibility :	2.28

Safety of [ 3270-97-1 ]

Signal Word:	Warning	Class:	N/A
Precautionary Statements:	P261-P305+P351+P338	UN#:	N/A
Hazard Statements:	H315-H319-H335	Packing Group:	N/A
GHS Pictogram:

Application In Synthesis of [ 3270-97-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

Upstream synthesis route of [ 3270-97-1 ]
Downstream synthetic route of [ 3270-97-1 ]

[ 3270-97-1 ] Synthesis Path-Upstream 1~3

1
[ 67-56-1 ]
[ 156-83-2 ]
[ 3270-97-1 ]

Yield	Reaction Conditions	Operation in experiment
84%	for 44 h; Reflux	To a solution of 9.2 g (0.40 mol) sodium in 320 ml methanol were added 28.9 g (0.20 mol) 2,4-diamino-6-chloropyrimidine. The mixture was heated under reflux with stirring for 44 h. After the reaction was ended the precipitated NaCl was separated off and the solution was concentrated to dryness. The residue in 300 ml ethanol was heated to boiling and filtered hot. The product precipitated out of the filtrate on standing overnight. Recrystallization of the mother liquor likewise afforded product. After drying, 6-methoxy-2,4-diaminopyrimidine was obtained as a white solid (58.8 g, 84percent). m.pt.: 166-169° C. ¹H-NMR (300 MHz, d₆-DMSO): δ=3.18 (s, 3 H, 6-OMe), 5.06 (s, 1H, 5-H), 5.94 (s, 2 H, NH₂), 6.05 (s, 2 H, NH₂). ¹³C-NMR (125 MHz, d₆-DMSO): δ=52.8 (6-OMe), 76.1 (5-C), 163.3 (2-C), 166.3 (4-C), 170.8 (6-C).

Reference： [1] Organic and Biomolecular Chemistry, 2010, vol. 8, # 10, p. 2397 - 2407
[2] Patent: US2015/209257, 2015, A1, . Location in patent: Paragraph 0239; 0240; 0241; 0242; 0243
[3] Journal of Heterocyclic Chemistry, 1982, vol. 19, p. 917 - 921

2
[ 156-83-2 ]
[ 124-41-4 ]
[ 3270-97-1 ]

Reference： [1] Journal of Medicinal Chemistry, 2014, vol. 57, # 23, p. 10080 - 10100
[2] Bioorganic and Medicinal Chemistry, 1998, vol. 6, # 7, p. 1057 - 1067
[3] Patent: US2016/159750, 2016, A1, . Location in patent: Paragraph 0370-0374

3
[ 67-56-1 ]
[ 156-83-2 ]
[ 124-41-4 ]
[ 3270-97-1 ]

Reference： [1] Journal of the American Chemical Society, 1951, vol. 73, p. 2864,2867
[2] Patent: US2584024, 1948, ,

[ 3270-97-1 ] Synthesis Path-Downstream 1~16

1
[ 67-56-1 ]
[ 156-83-2 ]
[ 124-41-4 ]
[ 3270-97-1 ]

Reference： [1]Journal of the American Chemical Society,1951,vol. 73,p. 2864,2867
[2]Patent: US2584024,1948,

2
[ 3270-97-1 ]
[ 98143-11-4 ]

Yield	Reaction Conditions	Operation in experiment
92%	With acetic acid; sodium nitrite; In water; at 20 - 60℃; for 1h;	(Essigsaeure=acetic acid) To a stirred solution of 7.0 g (0.05 mol) <strong>[3270-97-1]6-methoxy-2,4-diaminopyrimidine</strong> in 100 ml acetic acid (10% conc. in water) at 50-60 C. was added dropwise over a period of 30 min a solution of 4.55 g (0.07 mol) sodium nitrite in 20 ml water. The solution was stirred at this temperature for a further 30 min and then stirred at room temperature overnight. The filtrate was filtered off with suction, washed with water and dried. 5-Nitroso-<strong>[3270-97-1]2,4-diamino-6-methoxypyrimidine</strong> (7.80 g, 92%) was obtained as a violet solid. m.pt.: 250 C. (dec.) 1H-NMR (300 MHz, d6-DMSO): delta=4.04 (s, 3 H, 6-OMe), 7.79 (s,1H, NH2), 7.85 (s,1H, NH2), 8.01 (s,1H, NH2), 10.10 (s, 1H, NH2). 13C-NMR (125 MHz, d6-DMSO): delta=54.5 (6-OMe), 140.0 (5-C), 151.2 (2-C), 163.8 (4-C), 171.4 (6-C).

Reference： [1]Journal of Medicinal Chemistry,2014,vol. 57,p. 10080 - 10100
[2]Patent: US2015/209257,2015,A1 .Location in patent: Paragraph 0244; 0245; 0246; 0247; 0248; 0249
[3]Organic and Biomolecular Chemistry,2010,vol. 8,p. 2397 - 2407
[4]Journal of the American Chemical Society,1951,vol. 73,p. 2864,2867

3
[ 67-56-1 ]
[ 156-83-2 ]
[ 3270-97-1 ]

Yield	Reaction Conditions	Operation in experiment
84%	With sodium; for 44h;Reflux;	To a solution of 9.2 g (0.40 mol) sodium in 320 ml methanol were added 28.9 g (0.20 mol) 2,4-diamino-6-chloropyrimidine. The mixture was heated under reflux with stirring for 44 h. After the reaction was ended the precipitated NaCl was separated off and the solution was concentrated to dryness. The residue in 300 ml ethanol was heated to boiling and filtered hot. The product precipitated out of the filtrate on standing overnight. Recrystallization of the mother liquor likewise afforded product. After drying, 6-methoxy-2,4-diaminopyrimidine was obtained as a white solid (58.8 g, 84%). m.pt.: 166-169 C. 1H-NMR (300 MHz, d6-DMSO): delta=3.18 (s, 3 H, 6-OMe), 5.06 (s, 1H, 5-H), 5.94 (s, 2 H, NH2), 6.05 (s, 2 H, NH2). 13C-NMR (125 MHz, d6-DMSO): delta=52.8 (6-OMe), 76.1 (5-C), 163.3 (2-C), 166.3 (4-C), 170.8 (6-C).

Reference： [1]Organic and Biomolecular Chemistry,2010,vol. 8,p. 2397 - 2407
[2]Patent: US2015/209257,2015,A1 .Location in patent: Paragraph 0239; 0240; 0241; 0242; 0243
[3]Journal of Heterocyclic Chemistry,1982,vol. 19,p. 917 - 921

4
[ 3270-97-1 ]
[ 39667-14-6 ]
[ 73576-14-4 ]

Reference： [1]Journal of Medicinal Chemistry,1980,vol. 23,p. 535 - 541

5
[ 156-83-2 ]
[ 124-41-4 ]
[ 3270-97-1 ]

Yield	Reaction Conditions	Operation in experiment
	In methanol; toluene; at 80℃;Inert atmosphere; Dean-Stark;	The compound was synthesized as in Synthetic example 1a-1 except that 2, 4-diamino-6-methoxypyrimidine was used as a starting material in place of 2,4-diamino-6-methylpyrimidine in Synthetic example 1a-1 and that the following processes were performed. 2,4-Diamino-6-methoxypyrimidine was synthesized in accordance with the method described in J. Bioorg. Med. Chem., 1998, vol. 6, pp. 1057-1067 and was used without purification for the subsequent step. 2,4-Diamino-6-chloropyrimidine (21.9 g: 150 mmol) was added to methanol (20 mL) and toluene (80 mL) under a nitrogen gas flow, and a solution of sodium methoxide in 28% methanol (153 mL) was dropwise added thereto at room temperature. Subsequently, the mixture was refluxed in a hot water bath at 80 C. while the solvent was being distilled off by a Dean-Stark trap. During the reflux, toluene (60 mL) was added to the reaction solution, followed by refluxing. The reaction system was cooled to 50 C., and a mixture of N-ethylpyrrolidone (60 mL) and methyl benzoate (53 g: 485 mol) was added thereto, followed by stirring with heating at 45 C. for 3 hours. The temperature of the reaction system was decreased to room temperature, and then the reaction solution was added to a liquid mixture of toluene (200 mL), water (200 mL), and acetic acid (43 mL). The organic layer was separated, and 150 mL of 1N aqueous acetic acid solution was added thereto under heating for separation. This separation step was repeated twice, and water (200 mL) was added to the organic layer, followed by cooling to room temperature to precipitate the product. The crude product was recrystallized from acetonitrile to yield 30 g (yield: 57%) of compound (1-9). The NMR spectrum of produced compound (1-9) is as follows. 1H-NMR (solvent: d6-DMSO, standard: tetramethylsilane) delta (ppm) 3.90 (3H, s) 7.39 (1H, s) 7.45-7.70 (6H, m) 7.90-8.05 (4H, m) 10.78 (1H, s) 11.00 (1H, s)

Reference： [1]Journal of Medicinal Chemistry,2014,vol. 57,p. 10080 - 10100
[2]Bioorganic and Medicinal Chemistry,1998,vol. 6,p. 1057 - 1067
[3]Patent: US2016/159750,2016,A1 .Location in patent: Paragraph 0370-0374

6
[ 3270-97-1 ]
[ 38870-89-2 ]
2-Methoxy-N-[4-methoxy-6-(2-methoxy-acetylamino)-pyrimidin-2-yl]-acetamide [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry,1998,vol. 6,p. 1057 - 1067

7
[ 3270-97-1 ]
[ 4755-77-5 ]
N-[4-(Ethoxyoxalyl-amino)-6-methoxy-pyrimidin-2-yl]-oxalamic acid ethyl ester [ No CAS ]

Reference： [1]Bioorganic and Medicinal Chemistry,1998,vol. 6,p. 1057 - 1067

9
[ 3270-97-1 ]
[ 106-51-4 ]
2-amino-4-methoxy-9<i>H</i>-1,3,9-triaza-fluoren-6-ol [ No CAS ]

Reference： [1]Synlett,2004,p. 1039 - 1043
[2]Bioorganic and Medicinal Chemistry,2006,vol. 14,p. 7282 - 7292

10
[ 3270-97-1 ]
[ 73576-23-5 ]

Reference： [1]Journal of Medicinal Chemistry,1980,vol. 23,p. 535 - 541

11
[ 3270-97-1 ]
[ 22715-33-9 ]

Reference： [1]Journal of the American Chemical Society,1951,vol. 73,p. 2864,2867
[2]Journal of Medicinal Chemistry,2014,vol. 57,p. 10080 - 10100

12
[ 3270-97-1 ]
[ 102-52-3 ]
2-amino-4-methoxypyrido[2,3-d]pyrimidine [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
2.5 gm (40.5%)	With sodium hydrogencarbonate; In water; acetic acid;	EXAMPLE 73 2-Amino-4-methoxypyrido[2,3-d]pyrimidine A quantity of 4.94 gm of <strong>[3270-97-1]2,4-diamino-6-methoxypyrimidine</strong> is heated to boiling in 120 ml of glacial acetic acid and, after the addition of 6.4 ml of 1,1,3,3-tetramethoxypropane, left for a further 45 minutes at boiling temperature. Then, the glacial acetic acid is distilled off and evaporated several times with water, and the residue is taken up in 400 ml of water. After the addition of 5 gm of sodium bicarbonate, the residue is removed by suction filtration and discarded. The filtrate is extracted several times with chloroform, and the combined extracts are washed with sodium bicarbonate solution and then dried over sodium sulfate. The residue remaining after evaporation is purified on silica gel with chloroform and a chloroform/methanol mixture and then recrystallized from water. Yield: 2.5 gm (40.5%) of 2-amino-4-methoxy-pyrido[2,3-d]pyrimidine in the form of crystals, m.p.: 178-180 C. Elementary analysis Calc.: C 54.54 H 4.58 N 31.80. Found: 54.42 4.56 31.77.

Reference： [1]Patent: US4826528,1989,A

13
[ 3270-97-1 ]
2-amino-6-methoxy-7H-purine-8(9H)-thione [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2014,vol. 57,p. 10080 - 10100

14
[ 3270-97-1 ]
2-(2-amino-6-methoxy-9H-purin-8-ylthio)-N-(3,4-dimethoxyphenyl)acetamide [ No CAS ]

Reference： [1]Journal of Medicinal Chemistry,2014,vol. 57,p. 10080 - 10100

15
[ 93-58-3 ]
[ 3270-97-1 ]
C₁₉H₁₆N₄O₃ [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
85%	at 60℃; for 2h;	2,4-Diamino-6-chloropyrimidine (17.34 g: 120 mmol) and sodium methoxide (38.9 g) were sequentially added to t-butanol (60 mL) and N-ethylpyrrolidone (30 mL) under a nitrogen gas flow, followed by stirring with heating at 80 C. for 2 hours. The reaction solution was cooled to 60 C., and methyl benzoate (38.9 g: 288 mol) was dropwise added thereto, followed by stirring with heating at 60 C. for 2 hours. The reaction solution was added to a liquid mixture of iced water (130 mL) and concentrated hydrochloric acid (51 mL), followed by heating to 50 C. to completely dissolve the solid component. The organic layer was separated, and methanol (100 mL) and water (100 mL) were added thereto, followed by stirring under ice cooling for 1 hour. The precipitated product was collected by filtration, and the resulting crystals were washed with a poured methanol/water solvent mixture and then water. After ventilation drying at 50 C. for 13 hours, 38 g (yield: 85%) of compound (1-9) was yielded.

Reference： [1]Patent: US2016/159750,2016,A1 .Location in patent: Paragraph 0375

16
[ 3270-97-1 ]
[ 4755-77-5 ]
N-[4-(Ethoxyoxalyl-amino)-6-methoxy-pyrimidin-2-yl]-oxalamic acid ethyl ester [ No CAS ]

Yield	Reaction Conditions	Operation in experiment
	In pyridine; water;	EXAMPLE 3 Preparation of diethyl 6-methoxypyrimidine-2,4-dioxamate monohydrate: <strong>[3270-97-1]2,4-Diamino-6-methoxypyrimidine</strong> (3.78 g) is dissolved in anhydrous pyridine (20 ml) and thereto is added dropwise ethyloxalyl chloride (9.83 g) under ice cooling, and the mixture is stirred at room temperature for one hour. To the reaction mixture is added water, and the mixture is extracted with ethyl acetate. The organic layer is washed with water and saturated aqueous sodium chloride, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting solid is recrystallized from water-ethanol to give title compound (8.8 g) having the following physical properties. m.p. 132-134 C. IR (KBr) nu: 3625, 3530, 3420, 3010, 1740, 1610, 1530, 1475, 1400, 1305, 1210, 1170, 1100, 1050, 1015, 970, 840 cm-1. NMR (DMSO-d6) delta: 11.30 (1H, s), 10.60 (1H, s), 7.03 (1H, s), 4.29 (4H, q), 3,87 (3H, s), 1.30 (3H, t), 1.25 (3H, t). Elementary analysis: Calcd.: C, 43.58; H, 5.06; N, 15.64 (%). Found: C, 43.75; H, 4.85; N, 15.89 (%).

Reference： [1]Patent: US4729995,1988,A

Recommend Products

Same Skeleton Products

Related Products

Isomers

Technical Information

• 1,4-Addition of an Amine to a Conjugated Enone • 1,4-Addition of an Amine to a Conjugated Enone • Acetal Formation • Amides Can Be Converted into Aldehydes • Amine Synthesis from Nitriles • Amine Synthesis from Nitriles • Amines Convert Acyl Chlorides into Amides • Amines Convert Esters into Amides • Azide Reduction by LiAlH4 • Azide Reduction by LiAlH4 • Basicity of Amines • Buchwald-Hartwig C-N Bond and C-O Bond Formation Reactions • Chan-Lam Coupling Reaction • Chichibabin Reaction • Diazotization Reaction • DIBAL Attack Nitriles to Give Ketones • Enamine Formation • Esters Are Reduced by LiAlH4 to Give Alcohols • Esters Hydrolyze to Carboxylic Acids and Alcohols • Ether Synthesis by Oxymercuration-Demercuration • Ethers Synthesis from Alcohols with Strong Acids • Formation of an Amide from an Amine and a Carboxylic Acid • Formation of an Amide from an Amine and a Carboxylic Acid • Grignard Reagents Transform Esters into Alcohols • Hemiaminal Formation from Amines and Aldehydes or Ketones • Hemiaminal Formation from Amines and Aldehydes or Ketones • Hofmann Elimination • Hofmann Rearrangement • Hydride Reductions • Hydrolysis of Imines to Aldehydes and Ketones • Imine Formation from Amines and Aldehydes or Ketones • Leuckart-Wallach Reaction • Mannich Reaction • Methylation of Ammonia • Methylation of Ammonia • Nitrosation of Amines • Nomenclature of Ethers • Peptide Bond Formation with DCC • Petasis Reaction • Preparation of Amines • Preparation of Ethers • Preparation of LDA • Primary Ether Cleavage with Strong Nucleophilic Acids • Reactions of Amines • Reactions of Ethers • Reduction of an Amide to an Amine • Reduction of an Amide to an Amine • Reductive Amination • Reductive Amination • Ring Opening of Azacyclopropanes • Ring Opening of Azacyclopropanes • Ring Opening of Oxacyclobutanes • Ring Opening of Oxacyclopropane • Specialized Acylation Reagents-Vilsmeier Reagent • Strecker Synthesis • Synthesis of 2-Amino Nitriles • Synthesis of Alcohols from Tertiary Ethers • The Nucleophilic Opening of Oxacyclopropanes • Ugi Reaction

Historical Records

Related Functional Groups of
[ 3270-97-1 ]

Ethers

[ 116436-03-4 ]

2,4-Diamino-6-ethoxypyrimidine

Similarity: 0.96

[ 155-90-8 ]

2-Amino-4-methoxypyrimidine

Similarity: 0.85

[ 186435-66-5 ]

6-Amino-2-methoxypyrimidin-4-ol

Similarity: 0.75

[ 36315-01-2 ]

2-Amino-4,6-dimethoxypyrimidine

Similarity: 0.73

[ 13566-48-8 ]

2-Methyl-4,6-dimethoxypyrimidine

Similarity: 0.67

Amines

[ 116436-03-4 ]

2,4-Diamino-6-ethoxypyrimidine

Similarity: 0.96

[ 100643-27-4 ]

2,6-Diaminopyrimidin-4-ol

Similarity: 0.92

[ 155-90-8 ]

2-Amino-4-methoxypyrimidine

Similarity: 0.85

[ 186435-66-5 ]

6-Amino-2-methoxypyrimidin-4-ol

Similarity: 0.75

[ 36315-01-2 ]

2-Amino-4,6-dimethoxypyrimidine

Similarity: 0.73

Related Parent Nucleus of
[ 3270-97-1 ]

Pyrimidines

[ 116436-03-4 ]

2,4-Diamino-6-ethoxypyrimidine

Similarity: 0.96

[ 100643-27-4 ]

2,6-Diaminopyrimidin-4-ol

Similarity: 0.92

[ 155-90-8 ]

2-Amino-4-methoxypyrimidine

Similarity: 0.85

[ 186435-66-5 ]

6-Amino-2-methoxypyrimidin-4-ol

Similarity: 0.75

[ 36315-01-2 ]

2-Amino-4,6-dimethoxypyrimidine

Similarity: 0.73

Ghs Precautionary Statements

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Purity	Size	Price	VIP Price	USA Stock *0-1 Day	Global Stock *5-7 Days	Quantity
{[ item.p_purity ]}	{[ item.pr_size ]}	Inquiry	{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]}	{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]}	Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]}	{[ item.pr_usastock ]}		{[ item.pr_chinastock ]}	{[ item.pr_remark ]}

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed
H304	May be fatal if swallowed and enters airways
H305	May be harmful if swallowed and enters airways
H310	Fatal in contact with skin
H311	Toxic in contact with skin
H312	Harmful in contact with skin
H313	May be harmful in contact with skin
H314	Causes severe skin burns and eye damage
H315	Causes skin irritation
H316	Causes mild skin irritation
H317	May cause an allergic skin reaction
H318	Causes serious eye damage
H319	Causes serious eye irritation
H320	Causes eye irritation
H330	Fatal if inhaled
H331	Toxic if inhaled
H332	Harmful if inhaled
H333	May be harmful if inhaled
H334	May cause allergy or asthma symptoms or breathing difficulties if inhaled
H335	May cause respiratory irritation
H336	May cause drowsiness or dizziness
H340	May cause genetic defects
H341	Suspected of causing genetic defects
H350	May cause cancer
H351	Suspected of causing cancer
H360	May damage fertility or the unborn child
H361	Suspected of damaging fertility or the unborn child
H361d	Suspected of damaging the unborn child
H362	May cause harm to breast-fed children
H370	Causes damage to organs
H371	May cause damage to organs
H372	Causes damage to organs through prolonged or repeated exposure
H373	May cause damage to organs through prolonged or repeated exposure
Environmental hazards
Code	Phrase
H400	Very toxic to aquatic life
H401	Toxic to aquatic life
H402	Harmful to aquatic life
H410	Very toxic to aquatic life with long-lasting effects
H411	Toxic to aquatic life with long-lasting effects
H412	Harmful to aquatic life with long-lasting effects
H413	May cause long-lasting harmful effects to aquatic life
H420	Harms public health and the environment by destroying ozone in the upper atmosphere

[ CAS No. 3270-97-1 ] {[proInfo.proName]}

Quality Control of [ 3270-97-1 ]

Related Doc. of [ 3270-97-1 ]

Product Details of [ 3270-97-1 ]

Calculated chemistry of [ 3270-97-1 ] Expand+

Physicochemical Properties

Pharmacokinetics

Lipophilicity

Druglikeness

Water Solubility

Medicinal Chemistry

Safety of [ 3270-97-1 ]

Application In Synthesis of [ 3270-97-1 ]

[ 3270-97-1 ] Synthesis Path-Upstream 1~3

[ 3270-97-1 ] Synthesis Path-Downstream 1~16

Technical Information

Related Functional Groups of [ 3270-97-1 ]

Ethers

Amines

Related Parent Nucleus of [ 3270-97-1 ]

Pyrimidines

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Related Functional Groups of
[ 3270-97-1 ]

Related Parent Nucleus of
[ 3270-97-1 ]